Join Us

We are 225,035 members in 83 forums discussing 163,852 topics.

Help with Abbreviations

Topic: Ibrance + Faslodex as 1st Tx Improves Outcomes for HR+ HER2- MBC

Forum: Stage IV/Metastatic Breast Cancer, Open to All To Contribute —

Topics here are started by members with a Stage IV/Metastatic Breast Cancer diagnosis, but open to all members to contribute to discussions. Please note that there is a separate forum, Stage IV/Metastatic Breast Cancer ONLY, where topics are open only to those members.

Posted on: Oct 29, 2020 12:59PM

Moderators wrote:

Early Results Suggest Ibrance Plus Faslodex as First Treatment Improves Outcomes for Metastatic Hormone-Receptor-Positive, HER2-Negative Breast Cancer
October 27, 2020

Adding Ibrance to Faslodex as a first treatment for advanced-stage or metastatic hormone-receptor-positive, HER2-negative breast cancer that either came back (recurred) more than 1 year after completing 5 or more years of hormonal therapy or was metastatic at first diagnosis improved progression-free survival compared to Faslodex alone. Read more...

To send a Private Message to the Mods:
Log in to post a reply